Anti Epilepsy Drugs Companies

Zydus Lifesciences launches generic Topiramate extended-release capsules in the US market: December 2023 launch expands patient access to this commonly used AED for seizure control.

Marinus Pharmaceuticals completes Phase 3 study of ganaxolone for treatment of seizures associated with Lennox-Gastaut syndrome: January 2024 milestone paves the way for potential regulatory approval of a novel treatment option for this specific seizure type.

GlaxoSmithKline (GSK) invests in research and development of new AEDs commitment to epilepsy treatment through ongoing research efforts exploring new mechanisms of action and improved drug delivery methods.

List of Anti Epilepsy Drugs Key Companies in the Market

• Novartis AG


• Johnson & Johnson Service, Inc.


• SK Biopharmaceuticals


• GlaxoSmithKline Plc


• Teva Pharmaceutical Industries Ltd.


• Pfizer, Inc.


• Bausch Health Companies Inc.


• Zogenix


• Eisai Co., Ltd.


• Reddy's Laboratories Ltd.


• Alkem Labs